9
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

Aminolevulinic acid photodynamic therapy for actinic keratoses and photorejuvenation

Pages 391-402 | Published online: 10 Jan 2014

References

  • Raab O. Ueber die wirkung fluoreszierenden stoffe auf infusorien. Z. Biol.39, 524–526 (1900).
  • Von Tappeiner H, Jodblauer A. Uber die wirkung der photodynamischen (fluorescierenden) staffe auf protozoan und enzyme. Dtsch. Arch. Klin. Med.80, 427–487 (1904).
  • Jesionek A, Von Tappeiner H. Behandlung der hautcarcinome nut fluorescierenden stoffen. Dtsch. Arch. Klin. Med.85, 223–227 (1905).
  • Hausman W. Die sensibilisierende wirkung des hamatoporphyrins. Biochem. Z.276–316 (1911).
  • Meyer-Betz F. Untersuchungen uber die bioloische (photodynamische) wirkung des hamatoporphyrins und anderer derivative des blut-und gallenfarbstoffs. Dtsch. Arch. Klin. Med.112, 476–503 (1913).
  • Auler H, Banzer G. Untersuchungen ueber die rolle der porphyrine bei geschwulstkranken menschen und tieren. Z. Krebsforsch.53, 65–68 (1942).
  • Figge FHJ, Weiland GS, Manganiello LDJ. Cancer detection and therapy. Affinity of neoplastic embryonic and traumatized tissue for porphyrins and metalloporphyrins. Proc. Soc. Exp. Biol. Med.68, 640 (1948).
  • Dougherty TJ, Kaufman JE, Goldfarb A et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res.38, 2628–2635 (1978).
  • Kennedy JC, Pottier RH, Pross DC et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experiences. J. Photochem. Photobiol.B6, 143–148 (1990).
  • Gold MH, Goldman MP. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol. Surg.30, 1077–1084 (2004).
  • Jeffes EW, McCullough JL, Weinstein GD et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J. Am. Acad. Dermatol.45(1), 96–104 (2001).
  • Jeffes EW. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis. J. Dermatolog. Treat.13(Suppl. 1), S19–S23 (2002)
  • Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch. Dermatol.139(10), 1313–1320 (2003).
  • Gold MH. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. Cutis69(6 Suppl.), 8–13 (2002).
  • Touma D, Yaar M, Whitehead S et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch. Dermatol.140(1), 33–40 (2004).
  • Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvenation. Dermatol. Surg.28(8), 742–744 (2002).
  • Gold MH, Bradshaw VL, Boring MM et al. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J. Drugs Dermatol.3(6 Suppl.), S6–S9 (2004).
  • Goldman MP, Atkin D, Kincad S. PDT/ALA in the treatment of actinic damage: real world experience. J. Lasers Surg. Med.14(S), 24 (2002).
  • Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J. Drugs Dermatol.3(1 Suppl.), S36–S39 (2004).
  • Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J. Drugs Dermatol.3(5), 548–551 (2004).
  • Alster TS, Tanzi EL, Welch EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J. Drugs Dermatol.4(1), 35–38 (2005).
  • Key DJ. Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmetic Derm.18, 31–36 (2005).
  • Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J. Cosmet. Laser Ther.7, 21–24 (2005).
  • Dover JS, Bhatia AC, Stewart B et al. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch. Dermatol.141(10), 1247–1252 (2005).
  • Gold MH, Bradshaw VL, Boring MM et al. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol. Surg.32(6), 795–801 (2006).
  • Data on file. Galderma.
  • Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J. Am. Acad. Dermatol.47, 258–262 (2002).
  • Bjerring P, Funk J, Poed-Petersen J et al. Randomized double blind study comparing photodynamic therapy (PDT) with Metvix® to PDT with placebo cream in actinic keratosis. Abstract accepted at the 29th Nordic Congress of Dermatology and Venereology, Gothenburg, Sweden (2001).
  • Freeman M, Vinciullo C, Francis D et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J. Dermatolog. Treat.14, 99–106 (2003).
  • Pariser DM, Lowe NJ, Stewart DM et al. Photodynamic therapy with topical methyl aminolevulinate (Metvix®) is effective and safe in the treatment of actinic keratosis: results of a prospective randomized trial. J. Am. Acad. Dermatol.48, 227–232 (2003).
  • Tarstedt M, Rosdahl I, Berne B et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm. Venereol.85(5), 424–428 (2005).
  • Data on file. Galderma.
  • Zane C, Capezzera R, Sala R, Venturini M, Calzavara-Pinton P. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg. Med.39(3), 203–209 (2007).
  • Nestor M, Gold MH, Kauvar A et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J. Drugs Dermatol.5, 140–154 (2006).
  • Gold MH, Nestor MS. Current treatments of actinic keratosis. J. Drugs Dermatol.5(2 Suppl.), 17–25 (2006).
  • Gold MH, Biron JA, Boring M, Bridges TM, Bradshaw VL. Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source. J. Drugs Dermatol.6(3), 319–322 (2007).
  • Fang JY, Lee WR, Shen SC, Fang YP, Hu CH. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br. J. Dermatol.151(1), 132–140 (2004).
  • Gold MH, Biron JA. A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy. J. Drugs Dermatol.5(8), 796–798 (2006).
  • Gold MH. Single-center, split-face, double-blind, randomized clinical trial of the efficacy of a trolamine-containing topical emulsion and a topical petrolatum-based product in reducing redness and peeling after treatment with a microlaser peel. Poster Presentation American of Academy Dermatology Annual Meeting. CA, USA (2006).
  • Gold MH, Ribet V, Gral N et al. Calming efficacy and tolerance of avene spring water gel after cepilatory laser treatment combined to healing cream in adults. Poster Presentation American of Academy Dermatology Annual Meeting. CA, USA (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.